@article{749c06a66cc24d18a65e9b2e6d3df227,
title = "Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever",
abstract = "There are no approved treatments for Lassa fever, which is endemic to the same regions of West Africa that were recently devastated by Ebola. Here we show that a combination of human monoclonal antibodies that cross-react with the glycoproteins of all four clades of Lassa virus is able to rescue 100% of cynomolgus macaques when treatment is initiated at advanced stages of disease, including up to 8 d after challenge.",
author = "Mire, {Chad E.} and Cross, {Robert W.} and Geisbert, {Joan B.} and Viktoriya Borisevich and Agans, {Krystle N.} and Deer, {Daniel J.} and Heinrich, {Megan L.} and Rowland, {Megan M.} and Augustine Goba and Mambu Momoh and Boisen, {Mathew L.} and Grant, {Donald S.} and Mohamed Fullah and Khan, {Sheik Humarr} and Fenton, {Karla A.} and Robinson, {James E.} and Branco, {Luis M.} and Garry, {Robert F.} and Geisbert, {Thomas W.}",
note = "Publisher Copyright: {\textcopyright} 2017 Nature America, Inc., part of Springer Nature. All rights reserved.",
year = "2017",
month = oct,
day = "1",
doi = "10.1038/nm.4396",
language = "English (US)",
volume = "23",
pages = "1146--1149",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Research",
number = "10",
}